Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer

International Journal of Oncology

Volumn 13, Issue 1, 1998, Pages 101-105

  Yokomizo, Akira ^a   Tindall, Donald J ^a   Hartmann, Lynn ^a   Jenkins, Robert B ^a   Smith, David I ^a   Liu, Wanguo ^a  

^a MAYO CLINIC   (United States)

Author keywords

Ovarian cancer; PTEN MMAC1 gene

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE DELETION; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031804873     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.1.101     Document Type: Article

References (28)

1. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics. CA Cancer J Clin 46: 5-27, 1996.
2. Lu KH, Weitzel JN, Kodali S, Welch WR, Berkowitz RS and Mok SC: A novel 4-cM minimally detected region on chromosome 11p15.1 associated with high grade nonmucinous epithelial ovarian carcinomas. Cancer Res 57: 347-390, 1997.
3. Bast RC Jr, Boyer CM, Xu FJ, Weiner J, Dabei R, Woolas R, Jacobs I and Berchuck A: Molecular approach to prevention and detection of epithelial ovarian cancer. J Cell Biochem 23 (Suppl.): 219-222, 1995.
4. Hartmann LC, Podratz KC, Keeney GL, Kamel NA, Edmonson JH, Grill JP, Su JQ, Katzmann JA and Roche PC: Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J Clin Oncol 12: 64-69, 1994.
5. Pejovic T: Genetic changes in ovarian cancer. Ann Med 27: 73-78, 1995.
6. Foster KA, Harrington P, Kerr J, Russell P, Di Cioccio RA, Scott IV, Jacobs I, Chenevix-Trench G, Ponder BA and Gayther SA: Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res 56: 3622-3625, 1996.
7. Takahashi H, Chiu HC, Bandera CA, Behbakht K, Liu PC, Couch FJ, Weber BL, Li Volsi VA, Furusato M, Rebane BA, Cardonick A, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC and Boyd J: Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res 56: 2738-2741, 1996.
8. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
9. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997.
10. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C and Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67, 1997.
11. Li DM and Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: 2124-2129, 1997.
12. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R and Tonks NK: P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: 9052-9057, 1997.
13. Pennisi E: New tumor suppressor found - twice. Science 275: 1876-1878, 1997.
14. Bast RC Jr, Boyer CM, Jacobs I, Xu FJ, Wu S, Weiner J, Kohler M and Berchuck A: Cell growth regulation in epithelial ovarian cancer. Cancer 71: 1597-1601, 1993.
15. Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, Podratz KC and Jenkins RB: Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393-2398, 1993.
16. Conover CA, Hartmann LC, Bradley S, Stalboerger P, Klee GG, Kalli KR and Jenkins RB: Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system. Exp Cell Res 238: 439-449, 1998.
17. Liu W, James CD, Frederick L, Anderete BE and Jenkins RB: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57: 5254-5257, 1997.
18. Liu W, Qian C, Comeau K, Brenn T, Furthmayr H and Francke U: Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome. Hum Mol Genet 5: 1581-1587, 1996.
19. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN and James CD: Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 26: 1396-1400, 1998.
20. Yokomizo A, Tindall DJ, Drabkin H, Gemmill R, Franklin W, Yang P, Sugio K, Smith DI and Liu W: PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene (In press).
21. Lo SH, Weisburg E and Chen LB: Tensin: a potential link between the cytoskeleton and signal tranduction. Bioessays 16: 817-823, 1994.
22. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663, 1997.
23. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997.
24. Kong D, Suzuki A, Zou T, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A: PTENI is frequently mutated in primary endometrial carcinomas. Nat Genet 17: 143-144, 1997.
25. Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ and Eng C: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16: 333-334, 1997.
26. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657-3659, 1997.
27. Yang-Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT and Schwartz PE: Allelic loss in ovarian cancer. Cancer Res 54: 546-551, 1993.
28. Sakurada A, Suzuki A, Sato M, Yamakawa H, Orikasa K, Uyeno S, Ono T, Ohuchi N, Fujimura S and Horii A: Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn J Cancer Res 88: 1025-1028, 1997.